Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 349.92
+9.70 (2.85%)
At close: Oct 3, 2025
Elevance Health Market Cap
Elevance Health has a market cap or net worth of 58.57 billion as of October 3, 2025. Its market cap has decreased by -38.17% in one year.
Market Cap
58.57B
Enterprise Value
74.71B
Revenue
138.14B
Ranking
n/a
PE Ratio
14.97
Stock Price
349.92
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from 2.89B to 58.57B, an increase of 1,924.96%. That is a compound annual growth rate of 13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 58.57B | -14.30% |
| Dec 31, 2024 | 68.34B | -21.43% |
| Dec 29, 2023 | 86.98B | -14.45% |
| Dec 30, 2022 | 101.68B | 22.37% |
| Dec 31, 2021 | 83.09B | 42.06% |
| Dec 31, 2020 | 58.49B | 1.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.55B |
| Haleon | 29.53B |
| Smith & Nephew | 11.64B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |